Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gozdz A, Vashishta A, Kalita K, Szatmari E, Zheng JJ, Tamiya S, et al. Cisplatin-mediated activation of extracellular signal-regulated kinases 1/2 (ERK1/2) by inhibition of ERK1/2 phosphatases. J Neurochem. 2008;106:2056–67. https://doi.org/10.1111/j.1471-4159.2008.05550.x
Kang TH, Kim KT. Negative regulation of ERK activity by VRK3-mediated activation of VHR phosphatase. Nat Cell Biol. 2006;8:863–9. https://doi.org/10.1038/ncb1447
Kang TH, Kim KT. VRK3-mediated inactivation of ERK signaling in adult and embryonic rodent tissues. BBA Mol Cell Res. 2008;1783:49–58. https://doi.org/10.1016/j.bbamcr.2007.10.011
Komurov K, Padron D, Cheng T, Roth M, Rosenblatt KP, White MA. Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling. J Biol Chem. 2010;285:21134–42. https://doi.org/10.1074/jbc.M110.137828.
Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science. 2002;298:1912–34. https://doi.org/10.1126/science.1075762.
Montes de Oca R, Shoemaker CJ, Gucek M, Cole RN, Wilson KL. Barrier-to-autointegration factor proteome reveals chromatin-regulatory partners. PLoS One. 2009;4:e7050. https://doi.org/10.1371/journal.pone.0007050.
Nichols RJ, Traktman P. Characterization of three paralogous members of the Mammalian vaccinia related kinase family. J Biol Chem. 2004;279:7934–46. https://doi.org/10.1074/jbc.M310813200
Park CH, Ryu HG, Kim SH, Lee D, Song H, Kim KT. Presumed pseudokinase VRK3 functions as a BAF kinase. BBA Mol Cell Res. 2015;1853:1738–48. https://doi.org/10.1016/j.bbamcr.2015.04.007.
Sanz-Garcia M, Lopez-Sanchez I, Lazo PA. Proteomics identification of nuclear Ran GTPase as an inhibitor of human VRK1 and VRK2 (vaccinia-related kinase) activities. Mol Cell Proteomics. 2008;7:2199–214. https://doi.org/10.1074/mcp.M700586-MCP200.
Scheeff ED, Eswaran J, Bunkoczi G, Knapp S, Manning G. Structure of the pseudokinase VRK3 reveals a degraded catalytic site, a highly conserved kinase fold, and a putative regulatory binding site. Structure. 2009;17:128–38. https://doi.org/10.1016/j.str.2008.10.018.
Vega FM, Gonzalo P, Gaspar ML, Lazo PA. Expression of the VRK (vaccinia-related kinase) gene family of p53 regulators in murine hematopoietic development. FEBS Lett. 2003;544:176–80. https://doi.org/10.1016/S0014-5793(03)00501-5
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this entry
Cite this entry
Moura, D.S., Cantarero, L., Martín-Doncel, E., Campillo-Marcos, I., Lazo, P.A. (2018). VRK3. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_563
Download citation
DOI: https://doi.org/10.1007/978-3-319-67199-4_563
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67198-7
Online ISBN: 978-3-319-67199-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences